HUP0002085A3 - Transdermal patch for estrogen agonist-antagonist therapy - Google Patents

Transdermal patch for estrogen agonist-antagonist therapy

Info

Publication number
HUP0002085A3
HUP0002085A3 HU0002085A HUP0002085A HUP0002085A3 HU P0002085 A3 HUP0002085 A3 HU P0002085A3 HU 0002085 A HU0002085 A HU 0002085A HU P0002085 A HUP0002085 A HU P0002085A HU P0002085 A3 HUP0002085 A3 HU P0002085A3
Authority
HU
Hungary
Prior art keywords
transdermal patch
estrogen agonist
antagonist therapy
antagonist
therapy
Prior art date
Application number
HU0002085A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HU0002085D0 publication Critical patent/HU0002085D0/hu
Publication of HUP0002085A2 publication Critical patent/HUP0002085A2/hu
Publication of HUP0002085A3 publication Critical patent/HUP0002085A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
HU0002085A 1999-06-01 2000-05-31 Transdermal patch for estrogen agonist-antagonist therapy HUP0002085A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13716499P 1999-06-01 1999-06-01

Publications (3)

Publication Number Publication Date
HU0002085D0 HU0002085D0 (en) 2000-08-28
HUP0002085A2 HUP0002085A2 (en) 2001-03-28
HUP0002085A3 true HUP0002085A3 (en) 2002-09-30

Family

ID=22476088

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002085A HUP0002085A3 (en) 1999-06-01 2000-05-31 Transdermal patch for estrogen agonist-antagonist therapy

Country Status (16)

Country Link
EP (1) EP1057480B1 (hu)
JP (1) JP2001002588A (hu)
KR (1) KR20010029770A (hu)
AT (1) ATE269698T1 (hu)
AU (1) AU3781000A (hu)
CA (1) CA2310272A1 (hu)
CO (1) CO5170459A1 (hu)
DE (1) DE60011710T2 (hu)
DK (1) DK1057480T3 (hu)
ES (1) ES2220346T3 (hu)
HU (1) HUP0002085A3 (hu)
IL (1) IL136376A0 (hu)
NZ (1) NZ504868A (hu)
PE (1) PE20010207A1 (hu)
PT (1) PT1057480E (hu)
ZA (1) ZA200002693B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5271709A1 (es) * 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos
PT1229909E (pt) * 2000-06-01 2004-04-30 Watson Pharmaceiticals Inc Entrega transdermica de lasofoxifeno
US20140067048A1 (en) 2012-09-06 2014-03-06 Edwards Lifesciences Corporation Heart Valve Sealing Devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207437D0 (en) * 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
DE4407742C1 (de) * 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
US6034102A (en) * 1996-11-15 2000-03-07 Pfizer Inc Atherosclerosis treatment
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
NZ504868A (en) 2001-09-28
DE60011710D1 (de) 2004-07-29
ATE269698T1 (de) 2004-07-15
PT1057480E (pt) 2004-10-29
CO5170459A1 (es) 2002-06-27
HUP0002085A2 (en) 2001-03-28
JP2001002588A (ja) 2001-01-09
AU3781000A (en) 2000-12-07
DE60011710T2 (de) 2005-06-30
DK1057480T3 (da) 2004-11-08
EP1057480A2 (en) 2000-12-06
EP1057480A3 (en) 2002-01-09
ES2220346T3 (es) 2004-12-16
EP1057480B1 (en) 2004-06-23
CA2310272A1 (en) 2000-12-01
IL136376A0 (en) 2001-06-14
PE20010207A1 (es) 2001-02-28
KR20010029770A (ko) 2001-04-16
ZA200002693B (en) 2001-11-30
HU0002085D0 (en) 2000-08-28

Similar Documents

Publication Publication Date Title
GB2328375B (en) Transdermal patch
AU5057100A (en) Device for carrying out proton therapy
EP1170020A4 (en) EXTERNAL USE PADS
AU6940300A (en) Self-spotting apparatus for free-weights
AU1050401A (en) Device for cardiac therapy
GB2348139B (en) Electrotherapy apparatus
EP1280485A4 (en) TRANSDERMAL STAMP FOR IMPROVED MEDICINE
PL350167A1 (en) Medicament for treating hypertension
AU7697000A (en) Stereotactic apparatus
IL147749A0 (en) Methods for treating therapy-resistant tumors
GB9918735D0 (en) Transdermal patches
GB2351443B (en) Electrotherapy apparatus
HUP0002085A2 (en) Transdermal patch for estrogen agonist-antagonist therapy
GB2350935B (en) Antenna apparatus
GB2352091B (en) Patch antenna
AU1972200A (en) Treatment for fabrics
GB9927135D0 (en) Ostomy patches
AU6176900A (en) Device for stereotactic radiotherapy
AU3821800A (en) Auxiliary device for serving
AU6319600A (en) Patch
AU2577200A (en) Fabric for radiating astro-energy
AU3808800A (en) Compounds for use in therapy
HU9900326V0 (en) Storning device for auto-wheel or tyre
AU2806600A (en) Apparatus for electro-dipcoating
GB2389048B (en) Electrotherapy apparatus